NEFL and amyotrophic lateral sclerosis: Research on circulating biomarkers, such as NfL, miRNA, and TDP-43, in blood shows significant promise in aiding the early diagnosis and prognosis of ALS, offering potential tools to differentiate ALS from other neurodegenerative conditions and better understand disease progression.